Phosphate handling in CKD-MBD from stage 3 to dialysis and the three strengths of lanthanum carbonate

Author： Cozzolino Mario Bruschetta Elena Cusi Daniele Montanari Emanuele Giovenzana Maria Enrica Galassi Andrea

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.16, 2012-11, pp. : 2337-2353

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lanthanum Carbonate: A Review of its Use in Lowering Serum Phosphate in Patients with End-Stage Renal Disease

By Curran Monique P. Robinson Dean M.

Drugs, Vol. 69, Iss. 16, 2009-11 ,pp. : 2329-2349

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics of the Phosphate Binder Lanthanum Carbonate

By Damment Stephen J.P. Pennick Michael

Clinical Pharmacokinetics, Vol. 47, Iss. 9, 2008-01 ,pp. : 553-563

Adis International

Access to resources Recommend Favorite

Lanthanum carbonate for the treatment of hyperphosphataemia in renal failure and dialysis patients

By Albaaj Fouad Hutchison Alastair J

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 2, 2005-02 ,pp. : 319-328

Informa Healthcare

Access to resources Recommend Favorite

Lanthanum Carbonate - A New Phosphate Binding Drug in Advanced Renal Failure

Current Medicinal Chemistry, Vol. 25, Iss. 1, 2018-01 ,pp. : 113-117

Bentham Science Publishers

Access to resources Recommend Favorite

Lanthanum Carbonate

By Tracy Swainston Harrison Scott L.J.

Drugs, Vol. 64, Iss. 9, 2004-01 ,pp. : 985-996

Adis International

Access to resources Recommend Favorite